z-logo
open-access-imgOpen Access
Difference in central nerve system metastasis during gefitinib or erlotinib therapy in patients with EGFR-mutated non-small cell lung cancer: a retrospective study
Author(s) -
Kazushi Yoshida,
Shintaro Kanda,
Hideaki Shiraishi,
Keiko Goto,
Kota Itahashi,
Yasushi Goto,
Hidehito Horinouchi,
Yutaka Fujiwara,
Hiroshi Nokihara,
Noboru Yamamoto,
Yuichiro Ohe
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.03.61
Subject(s) - erlotinib , gefitinib , medicine , oncology , brain metastasis , epidermal growth factor receptor , lung cancer , metastasis , tyrosine kinase inhibitor , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom